Leading 20+ years investments in differentiated innovations for spine surgery
We are a private equity healthtech investment firm with the world's largest portfolio of majority-owned differentiated spine technology companies
A Growing Problem
Each year, over 266 million people worldwide suffer from degenerative spine disease. At KIC Ventures, we recognize that as people live longer, more active lifestyles, they are increasingly likely to experience disc degeneration and back pain that may require surgery. Traditional spinal fusion performed by spine surgeons limits natural spine movement, often resulting in complications and costly revision surgeries. Many patients seek temporary relief from Interventional Pain Management (IPM) physicians, relying on opioids or spinal cord stimulators—treatments that fail to address the root cause.
Shaping the Future of Spine Care
We are leading the global transition of spine surgery into outpatient centers with our proprietary LESS™ Exposure Spine Surgery philosophy. This approach drives the development of LESS™ Exposure Advanced Spine Technologies (LEAST™), delivering 10x advancements in spine innovations. Through the development, acquisition, and commercialization of pioneering patented technologies, we are transforming spine care for physicians and patients alike.
The growing transition to ambulatory surgery centers (ASCs) has fueled demand for our NANISX’s LESS™ invasive spine technologies, which restore natural anatomy, reduce anesthesia risks, and shorten recovery times. This safer, cost-effective approach enables physicians to provide early interventions, while our AxioMed motion-preserving solutions minimize the need for fusion.
A Commitment to Long-Term Value Creation
We deeply value our investors who take a long-term position with us, enabling us to remain nimble and focus on growing value and adoption, with revenues naturally following as a result. Through our private equity model, where we own and operate a portfolio of companies, investors benefit from multiple opportunities for returns as our portfolio companies achieve strategic exits. Beyond financial growth, we offer the chance to invest in transformative solutions that could directly impact your life and the lives of those you care about.
Key Solutions
Focus Areas
At the core of our strategy is an urgent but disciplined approach to selecting niche areas where our strengths lie, aiming to develop best in class solutions with significant market growth potential over the next decade.
Featured Studies
Kingsley R Chin^, Jason A Seale, Carl A Bruce, Warren D Yu, Steven C Anagnost, Vivek P Kushwaha, Roger D Sung, Josue Gabriel, Craig S Meyer, Neil R Crawford, Vito Lore
Kingsley R. Chin^, Jason A. Seale, Erik Spayde, William M. Costigan, Nishant Gohel, Daniel Aloise, Vito Lore.
InSpan Slim
Track Record
200,000+
DEVICES IMPLANTED
100+
GLOBAL PATENTS
35+
US FDA APPROVED DEVICES
80+
INVESTORS: 50 US
30 INTL | 14 COUNTRIES
$85M+
INVESTED CASH:
$60M+ FOUNDERS |
$8M+ INVESTORS|
$17M+ PHYSICIANS
$300M
PORTFOLIO REVENUES
90+
RESEARCH PAPERS
10+
ACQUISITIONS & SALE
13+
COUNTRIES TECHNOLOGIES BEEN USED
$20M+
INVESTED DEBT